Related Experiment Video
Updated: Apr 1, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
14.0K
Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer
Marwan Ghosn1, Alain Dagher1, Fadi El-Karak1
1Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University , Beirut , Lebanon .
Journal of Biomedical Research
|October 8, 2015
Abstract:
We report a case of metastatic castration-resistant prostate cancer, who received prior treatment with docetaxel and was then given cabazitaxel as salvage therapy. The patient was monitored by prostate-specific antigen doubling time and prostate-specific antigen absolute value. The prostate-specific antigen doubling time was found to be a good response predictor in the patient.
